Aprepitant, Granisetron, and Dexamethasone for Prevention of Chemotherapy-Induced Nausea and Vomiting After High-Dose Melphalan in Autologous Transplantation for Multiple Myeloma: Results of a Randomized, Placebo-Controlled Phase III Trial
出版年份 2014 全文链接
标题
Aprepitant, Granisetron, and Dexamethasone for Prevention of Chemotherapy-Induced Nausea and Vomiting After High-Dose Melphalan in Autologous Transplantation for Multiple Myeloma: Results of a Randomized, Placebo-Controlled Phase III Trial
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 32, Issue 30, Pages 3413-3420
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2014-09-16
DOI
10.1200/jco.2013.55.0095
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effectiveness and Safety of Antiemetic Aprepitant in Japanese Patients Receiving High-Dose Chemotherapy Prior to Autologous Hematopoietic Stem Cell Transplantation
- (2013) Mayako Uchida et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Risk factors of chemotherapy-induced nausea and vomiting: Index for personalized antiemetic prophylaxis
- (2013) Ikuo Sekine et al. CANCER SCIENCE
- Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials
- (2013) Luigi Celio et al. Future Oncology
- Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study
- (2013) Alexander Molassiotis et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Naomi Mizukami et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation
- (2013) Mayako Uchida et al. PHARMACOTHERAPY
- Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer
- (2013) Michiyasu Murakami et al. SUPPORTIVE CARE IN CANCER
- Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
- (2013) Lee Schwartzberg et al. SUPPORTIVE CARE IN CANCER
- Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study
- (2013) Delva Deauna-Limayo et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Prevention of Nausea and Vomiting Associated with Stem Cell Transplant: Results of a Prospective, Randomized Trial of Aprepitant Used with Highly Emetogenic Preparative Regimens
- (2012) Patrick J. Stiff et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2011) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- Aprepitant Pharmacokinetics and Assessing the Impact of Aprepitant on Cyclophosphamide Metabolism in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation
- (2011) Joseph S. Bubalo et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A Triple-Drug Combination to Prevent Nausea and Vomiting Following BEAM Chemotherapy Before Autologous Hematopoietic Stem Cell Transplantation
- (2011) W. Pielichowski et al. TRANSPLANTATION PROCEEDINGS
- Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
- (2010) F. Roila et al. ANNALS OF ONCOLOGY
- The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (highdose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination
- (2010) K Jordan et al. BONE MARROW TRANSPLANTATION
- The NK1 receptor antagonist aprepitant does not alter the pharmacokinetics of high-dose melphalan chemotherapy in patients with multiple myeloma
- (2010) Gerlinde Egerer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
- (2010) Kenneth F. Schulz et al. PLOS MEDICINE
- Efficacy of aprepitant in patients receiving high-dose chemotherapy with hematopoietic stem cell support
- (2009) Betsy Paul et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started